Low Levels of Urinary PSA Better Identify Prostate Cancer Patients
Serum prostatic specific antigen (PSA) has proven to have limited accuracy in early diagnosis and in making clinical decisions about different therapies for prostate cancer (PCa). This is partially due to the fact that an increase in PSA in the blood is due to the compromised architecture of the pro...
Main Authors: | Sergio Occhipinti, Giulio Mengozzi, Marco Oderda, Andrea Zitella, Luca Molinaro, Francesco Novelli, Mirella Giovarelli, Paolo Gontero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3570 |
Similar Items
-
PSA screening for prostate cancer
by: Marcus V. Sadi -
PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium
by: Zi-Jian Song, et al.
Published: (2021-01-01) -
PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer
by: Vlad Cristian Munteanu, et al.
Published: (2020-10-01) -
Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01) -
Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: W. F. S. Busato, et al.
Published: (2015-04-01)